Duceman B W, Jacob S T
Biochem J. 1980 Sep 15;190(3):781-9. doi: 10.1042/bj1900781.
The amount and/or activity of DNA-dependent RNA polymerase I, Ii and III from resting liver, regenerating liver and a series of Morris hepatomas (5123D, 7800, 7777, 3924A) were determined after extraction of the enzymes from whole tissue homogenates and subsequent fractionation by DEAE-Sephadex column chromatography. When compared with resting liver, the tumours exhibited a characteristic enzyme pattern in which polymerase I, but not II, was increased. The increase in RNA polymerase I was proportional to the tumour growth rates. Alterations in polymerase III were confined to the most rapidly proliferating hepatomas. By contrast, all classes of RNA polymerase were found to be increased during liver regeneration. Relative to resting liver, the fastest growing tumour, 3924A, exhibited the highest activities and/or amounts of RNA polymerase I (8-fold) and III (5-fold) per g of tissue. These alterations in the tumour RNA polymerases were reflected in corresponding increases in the transcriptionally active (bound or chromatin-associated) enzyme population. The mechanisms underlying the augmented synthesis of RNA in vitro by bound polymerase I from hepatoma 3924A were elucidated by product analysis. The results indicated that, relative to liver RNA polymerase I, the tumour enzyme produced more nascent RNA chains and elongated these chains at a faster rate. The number of 3'-termini, as measured by incorporation into uridine, was higher in the hepatoma even under conditions which prevented re-initiation. suggesting increased amount of transcriptionally active RNA polymerase I in the tumour.
从静止肝脏、再生肝脏以及一系列Morris肝癌(5123D、7800、7777、3924A)中提取DNA依赖性RNA聚合酶I、II和III,经全组织匀浆后,再通过DEAE - 葡聚糖凝胶柱色谱法进行分级分离,测定这些酶的含量和/或活性。与静止肝脏相比,肿瘤呈现出一种特征性的酶谱模式,其中聚合酶I增加,而聚合酶II未增加。RNA聚合酶I的增加与肿瘤生长速率成正比。聚合酶III的变化仅限于增殖最快的肝癌。相比之下,在肝脏再生过程中发现所有类型的RNA聚合酶都增加。相对于静止肝脏,生长最快的肿瘤3924A每克组织中RNA聚合酶I(8倍)和III(5倍)的活性和/或含量最高。肿瘤RNA聚合酶的这些变化反映在转录活性(结合或与染色质相关)酶群体的相应增加上。通过产物分析阐明了肝癌3924A中结合的聚合酶I在体外增强RNA合成的机制。结果表明,相对于肝脏RNA聚合酶I,肿瘤酶产生更多的新生RNA链,并以更快的速度延长这些链。即使在防止重新起始的条件下,通过尿苷掺入测量的3'-末端数量在肝癌中也更高,这表明肿瘤中转录活性RNA聚合酶I的数量增加。